Literature DB >> 1883387

Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene.

G Peterson1, S Barnes.   

Abstract

The effect of isoflavones on the growth of the human breast carcinoma cell lines, MDA-468 (estrogen receptor negative), and MCF-7 and MCF-7-D-40 (estrogen receptor positive), has been examined. Genistein is a potent inhibitor of the growth of each cell line (IC50 values from 6.5 to 12.0 micrograms/ml), whereas biochanin A and daidzein are weaker growth inhibitors (IC50 values from 20 to 34 micrograms/ml). The isoflavone beta-glucosides, genistin and daidzin, have little effect on growth (IC50 values greater than 100 micrograms/ml). The presence of the estrogen receptor is not required for the isoflavones to inhibit tumor cell growth (MDA-468 vs MCF-7 cells). In addition, the effects of genistein and biochanin A are not attenuated by overexpression of the multi-drug resistance gene product (MCF-7-D40 vs MCF-7 cells).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1883387     DOI: 10.1016/0006-291x(91)91423-a

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  38 in total

1.  4-Hydroxytamoxifen-induced cytotoxicity and bisphenol A: competition for estrogen receptors in human breast cancer cell lines.

Authors:  J B Lewis; C A Lapp; T E Schafer; J C Wataha; T M Randol; G S Schuster
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-05       Impact factor: 2.416

Review 2.  A systems approach to cancer therapy. (Antioncogenics + standard cytotoxics-->mechanism(s) of interaction).

Authors:  B A Teicher
Journal:  Cancer Metastasis Rev       Date:  1996-06       Impact factor: 9.264

3.  Phytoestrogens have agonistic and combinatorial effects on estrogen-responsive gene expression in MCF-7 human breast cancer cells.

Authors:  S T Willard; L S Frawley
Journal:  Endocrine       Date:  1998-04       Impact factor: 3.633

4.  Phytoestrogens and soy based infant formula.

Authors:  C Essex
Journal:  BMJ       Date:  1996-08-31

5.  Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents.

Authors:  Y Kakeji; B A Teicher
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

6.  Formation of polyhydroxylated isoflavones from the soybean seed isoflavones daidzein and glycitein by bacteria isolated from tempe.

Authors:  K Klus; W Barz
Journal:  Arch Microbiol       Date:  1995-12       Impact factor: 2.552

Review 7.  Isoflavones: estrogenic activity, biological effect and bioavailability.

Authors:  Daniela Cristina Vitale; Cateno Piazza; Barbara Melilli; Filippo Drago; Salvatore Salomone
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2013-03       Impact factor: 2.441

8.  Genistein affects HER2 protein concentration, activation, and promoter regulation in BT-474 human breast cancer cells.

Authors:  Mary S Sakla; Nader S Shenouda; Pete J Ansell; Ruth S Macdonald; Dennis B Lubahn
Journal:  Endocrine       Date:  2007-10-02       Impact factor: 3.633

9.  Isoflavonoid biosynthesis and accumulation in developing soybean seeds.

Authors:  Sangeeta Dhaubhadel; Brian D McGarvey; Ruthanne Williams; Mark Gijzen
Journal:  Plant Mol Biol       Date:  2003-12       Impact factor: 4.076

10.  MEK4 function, genistein treatment, and invasion of human prostate cancer cells.

Authors:  Li Xu; Yongzeng Ding; William J Catalona; Ximing J Yang; Wayne F Anderson; Borko Jovanovic; Kenji Wellman; Jaqueline Killmer; Xiaoke Huang; Karl A Scheidt; R Bruce Montgomery; Raymond C Bergan
Journal:  J Natl Cancer Inst       Date:  2009-07-28       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.